Limits...
Trends regarding percutaneous endoscopic gastrostomy

View Article: PubMed Central - PubMed

ABSTRACT

Percutaneous endoscopic gastrostomy (PEG) is widely used in patients requiring long-term tube feeding. Traditional PEG studies usually focused on practical, technical, and ethical issues. There have been little epidemiological studies on PEG utilization and services in Asia. We evaluated the changes in PEG utilization, patient selection, patient characteristics, and medical service in Taiwan from 1997 to 2010.

This retrospective study analyzed the data of patients admitted for PEG tube placement according to the International Classification of Diseases, Ninth Revision (procedure code 43.11) extracted from the National Health Insurance database between 1997 and 2010.

From 1997 to 2010, the incidence of PEG increased from 0.1 to 3.8/105 population and incidence of PEG among aged patients increased from 0.9 to 19.0/105 population. Compared 1997–2004 to 2005–2010 periods, the percentage of cerebrovascular diseases decreased and esophageal cancer increased in the later period. PEG was mainly performed in male patients and at medical centers. Medical costs, Charlson Comorbidity Index (CCI) scores, and post-PEG mortality rates were higher in the 2005–2010 period than in the 1997–2004 period.

PEG procedures are being increasingly performed in Taiwan, and changes in patient selection were noted. The seriousness of accompanying diseases, medical costs, and post-PEG mortality rates in patients undergoing PEG has increased. The present findings may help in the implementation of PEG, relocation of medical resources, and improvement of PEG-related care.

No MeSH data available.


Related in: MedlinePlus

Mortality rates measured at 3, 7, 14, 30, 45, 60, 180, and 360 days after percutaneous endoscopic gastrostomy (∗P < 0.05, ∗∗P < 0.001). PEG = percutaneous endoscopic gastrostomy.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4998481&req=5

Figure 3: Mortality rates measured at 3, 7, 14, 30, 45, 60, 180, and 360 days after percutaneous endoscopic gastrostomy (∗P < 0.05, ∗∗P < 0.001). PEG = percutaneous endoscopic gastrostomy.

Mentions: Compared between 1997 to 2004 and 2005 to 2010 periods, patients who underwent PEG in the later period has significantly lower percentages in local hospitals (4.7% vs 7.6%, P = 0.042) and significantly lower length of hospital stay (19.7 ± 34.0 vs 21.6 ± 42.2, P = 0.001); but has significantly higher medical costs (4395 ± 6259 vs 3550 ± 4034, P = 0.002) and higher CCI (3.17 ± 3.57 vs 3.64 ± 4.20, P < 0.001). The mortality rates at 3, 7, 14, 30, 45, 60, 180, and 360 days after PEG were all significantly higher in the 2005 to 2010 period (Fig. 3).


Trends regarding percutaneous endoscopic gastrostomy
Mortality rates measured at 3, 7, 14, 30, 45, 60, 180, and 360 days after percutaneous endoscopic gastrostomy (∗P < 0.05, ∗∗P < 0.001). PEG = percutaneous endoscopic gastrostomy.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4998481&req=5

Figure 3: Mortality rates measured at 3, 7, 14, 30, 45, 60, 180, and 360 days after percutaneous endoscopic gastrostomy (∗P < 0.05, ∗∗P < 0.001). PEG = percutaneous endoscopic gastrostomy.
Mentions: Compared between 1997 to 2004 and 2005 to 2010 periods, patients who underwent PEG in the later period has significantly lower percentages in local hospitals (4.7% vs 7.6%, P = 0.042) and significantly lower length of hospital stay (19.7 ± 34.0 vs 21.6 ± 42.2, P = 0.001); but has significantly higher medical costs (4395 ± 6259 vs 3550 ± 4034, P = 0.002) and higher CCI (3.17 ± 3.57 vs 3.64 ± 4.20, P < 0.001). The mortality rates at 3, 7, 14, 30, 45, 60, 180, and 360 days after PEG were all significantly higher in the 2005 to 2010 period (Fig. 3).

View Article: PubMed Central - PubMed

ABSTRACT

Percutaneous endoscopic gastrostomy (PEG) is widely used in patients requiring long-term tube feeding. Traditional PEG studies usually focused on practical, technical, and ethical issues. There have been little epidemiological studies on PEG utilization and services in Asia. We evaluated the changes in PEG utilization, patient selection, patient characteristics, and medical service in Taiwan from 1997 to 2010.

This retrospective study analyzed the data of patients admitted for PEG tube placement according to the International Classification of Diseases, Ninth Revision (procedure code 43.11) extracted from the National Health Insurance database between 1997 and 2010.

From 1997 to 2010, the incidence of PEG increased from 0.1 to 3.8/105 population and incidence of PEG among aged patients increased from 0.9 to 19.0/105 population. Compared 1997&ndash;2004 to 2005&ndash;2010 periods, the percentage of cerebrovascular diseases decreased and esophageal cancer increased in the later period. PEG was mainly performed in male patients and at medical centers. Medical costs, Charlson Comorbidity Index (CCI) scores, and post-PEG mortality rates were higher in the 2005&ndash;2010 period than in the 1997&ndash;2004 period.

PEG procedures are being increasingly performed in Taiwan, and changes in patient selection were noted. The seriousness of accompanying diseases, medical costs, and post-PEG mortality rates in patients undergoing PEG has increased. The present findings may help in the implementation of PEG, relocation of medical resources, and improvement of PEG-related care.

No MeSH data available.


Related in: MedlinePlus